The growing popularity of Ozempic and other GLP-1s in recent years is garnering greater attention from oncologists interested in how these drugs could affect cancer care and cancer rates.
Author: Mariah Taylor
Eugene Kim, MD, has been named surgeon-in-chief and associate director of surgery at Torrance, Calif.-based Cedars-Sinai Guerin Children's.
A University of Cambridge poll found 70% of people fear a late cancer diagnosis.
A Boston-based Harvard Medical School study found oncologists unsure how to handle artificial intelligence if it presents a treatment plan they would not recommend.
Cancer deaths are down over the past three decades, but cancerphobia is as strong as ever, Washington Post columnist Steven Petrow reported July 5.
Advertisement
Researchers at Tampa-based University of South Florida and Bloomington-based Indiana University found cisplatin is linked to increased hearing loss.
There are more than 18 million cancer survivors living in the U.S., but few primary care providers know how to care for this patient group. To close the gap, Houston-based the University of Texas MD Anderson Cancer Center is launching…
A surgeon at Miami-based Sylvester Comprehensive Cancer Center is the first in the U.S. to use a blue laser to treat early glottic cancer, a common type of laryngeal cancer.
Renton, Wash.-based Providence is launching a first-of-its-kind study to examine the real-world implementation of multi-cancer early-detection blood tests.
Hackathons — events wherein programmers come together for days at a time to solve a problem — are a staple in the technology community. Durham, N.C.-based Duke Health is using a similar model to get high school students excited about…